PATENT CLAIM ANALYSIS

Application Number: 16040684
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "006200"]

Abstract:
The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.

Claim (Index 11):
The insulin derivative of  claim 9 , wherein Ar is a phenyl group substituted by one or more \u2014B(OH) 2  groups and one or two fluorine atoms.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 95.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12935438', '14126215', '13224538', '12673516', '15121206']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8385242165306682
- 35 USC 102 Novelty (BERT): 0.5675893280417316
- Combined Prediction Score: 0.8114307276817745
- Mean Citation Score: 445.473044
- Max Citation Score: 501.0652
- Similarity Product: 344.6599369914293

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test